专利号:US-2025188022-A1 优先权日:2022-02-07 标 题 :Process for the preparation of nafamostat, camostat and their derivatives 发明人:AHMED RIYAZ; KUMAR GULSHAN; MAHAJAN SHEENA; Verma Praveen Kumar; CHAM PANKAJ SINGH; KUMAR AMIT; AHMED QAZI NAVEED; REDDY DUMBALA SRINIVASA; SHANKAR RAVI; SINGH PARVINDER PAL 权利人:COUNCIL SCIENT IND RES 摘要:The invention provides a novel, economical and practical route for the synthesis of an ester from acid and alcoholic functionalities using Trihalotriazine as coupling agent. Specifically, the invention provides a novel, economical and practical route for the preparation of Nafamostat and Camostat. Synthesis of p-guanidinobenzoic acid (Al) was also achieved from thiourea and p-aminobenzoic acid by using trihalotriazine as coupling reagent.
专利号:CN-220143394-U 优先权日:2023-06-21 标题 :A kind of synthesis device for the production of nafamostat mesylate
专利号:CN-119504499-A 优先权日:2024-11-13 标题 :Synthesis method of 6-amidino-2-naphthol mesylate
1: Wang W, Zhao J, Zhang X, Wang L, Zhang X, Zhang Z, Qian S. Comparison of Anticoagulant Effects of Nafamostat Mesilate and Heparin in Continuous Renal Replacement Therapy for Patients with High Bleeding Risk: A Meta-Analysis Systemic Review. Kidney Dis (Basel). 2026 Feb 3;12(1):302-317. doi: 10.1159/000550804. 2: Wang Y, He Q, Wen D, Xu R, Yu X, Zhao L. Efficacy and safety of nafamostat mesylate versus heparin anticoagulation in adult kidney disease patients using continuous renal replacement therapy: a systematic review and meta-analysis. Front Med (Lausanne). 2026 Feb 17;13:1713412. doi: 10.3389/fmed.2026.1713412. 3: Liu C, Yang Y, Ren J, Huang Y, Wei W, Li X, Wang F, Tang X, Fu P, Zhang L, Zhao Y. Nafamostat mesilate as anticoagulant for blood purification: a systematic review and meta-analysis. Crit Care. 2025 Dec 24;30(1):43. doi: 10.1186/s13054-025-05813-w.
合成参考文献
摘要:United States Patent Document., #4454338 摘要:Iyakuhin Kenkyu. Study of Medical Supplies., 17(1106), 1986